← FDA Drug Approvals (Drugs@FDA)

WEGOVY

NDA · New Drug Application · Sponsor: NOVO · Approved 2025-12-22

Drug application

FDA Application #

NDA218316

Application type

New Drug Application

Brand name

WEGOVY

Generic name

SEMAGLUTIDE

Active ingredients

SEMAGLUTIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

NOVO

Manufacturer

Novo Nordisk

First approval

2025-12-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown